Ronald Sluyter

Northfields Avenue
Wollongong, NSW 2522, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 104 publications

The P2X7 receptor: insights from the murine monoclonal antibody clone L4.

The P2X7 receptor: insights from the murine monoclonal antibody clone L4.

Journal: Purinergic signalling
Published: June 03, 2026

Impact of cryopreservation on immune cell subset frequencies in human peripheral blood mononuclear cells following assessment of monoclonal antibodies to CD39 and P2X7.

Impact of cryopreservation on immune cell subset frequencies in human peripheral blood mononuclear cells following assessment of monoclonal antibodies to CD39 and P2X7.

Journal: Purinergic signalling
Published: June 01, 2026

Molecular characterization of covRS mutations in M1UK Streptococcus pyogenes.

Molecular characterization of covRS mutations in M1UK Streptococcus pyogenes.

Journal: FEBS open bio
Published: March 30, 2026

Mass Cytometry Reveals Comparable Proportions of Leukocyte Subsets and Cell Surface P2X7 or CD39 on Human Peripheral Blood Mononuclear Cell Samples Isolated by Ficoll-Paque or SepMate Tube Density Gradient Centrifugation.

Mass Cytometry Reveals Comparable Proportions of Leukocyte Subsets and Cell Surface P2X7 or CD39 on Human Peripheral Blood Mononuclear Cell Samples Isolated by Ficoll-Paque or SepMate Tube Density Gradient Centrifugation.

Journal: Cells
Published: March 16, 2026

In vivo stimulation of natural killer T cells and downstream regulatory T cells to reduce acute graft-versus-host disease.

In vivo stimulation of natural killer T cells and downstream regulatory T cells to reduce acute graft-versus-host disease.

Journal: Annals of translational medicine
Published: January 30, 2026

Methodological guidelines for P2X receptor assays and data interpretation.

Methodological guidelines for P2X receptor assays and data interpretation.

Journal: Cell death & disease
Published: January 18, 2026

Immune imbalance between T helper 1, T helper 17 and regulatory T cells fuels amyotrophic lateral sclerosis pathogenesis: disease trajectory, diagnosis and therapeutic implications.

Immune imbalance between T helper 1, T helper 17 and regulatory T cells fuels amyotrophic lateral sclerosis pathogenesis: disease trajectory, diagnosis and therapeutic implications.

Journal: Journal of neuroinflammation
Published: November 21, 2025

Special Issue "Purinergic Signalling in Physiology and Pathophysiology 2.0".

Special Issue "Purinergic Signalling in Physiology and Pathophysiology 2.0".

Journal: International journal of molecular sciences
Published: November 12, 2025

Localized Delivery of Anti-CD40/PD-1 Immunotherapy via a Polymeric Implant is Efficacious, Remodels the Tumor Immune Microenvironment and Improves Safety in a PDAC Mouse Model.

Localized Delivery of Anti-CD40/PD-1 Immunotherapy via a Polymeric Implant is Efficacious, Remodels the Tumor Immune Microenvironment and Improves Safety in a PDAC Mouse Model.

Journal: Advanced healthcare materials
Published: August 03, 2025

Adeno-associated viral vectors encoding anti-P2X7 nanobodies reduce graft-versus-host disease in a humanised mouse model.

Adeno-associated viral vectors encoding anti-P2X7 nanobodies reduce graft-versus-host disease in a humanised mouse model.

Journal: Clinical & translational immunology
Published: June 26, 2025

Low- and high-dose post-transplant cyclophosphamide attenuates graft-versus-host disease with distinct effects on PD-1+ T cell subsets.

Low- and high-dose post-transplant cyclophosphamide attenuates graft-versus-host disease with distinct effects on PD-1+ T cell subsets.

Journal: Clinical science (London, England : 1979)
Published: June 02, 2025

Artificial Intelligence-Driven Nanoarchitectonics for Smart Targeted Drug Delivery.

Artificial Intelligence-Driven Nanoarchitectonics for Smart Targeted Drug Delivery.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: May 29, 2025
Showing 1-12 of 104

Last Updated: 09/26/2026